The US Food and Drug Administration has issued a warning to manufacturers of four different products, who were marketing under the guise as a potential cure for cancer. The FDA concerns stem from companies providing false hopes to patients, by marketing CBD as a cure-all. According to the FDA, CBD has not been proven to be effective as a medicine.
Scott Gottlieb, FDA Commissioner stated, “Substances that contain components of marijuana will be treated like any other products that make unproven claims to shrink cancer tumors.” The FDA has seemingly always been on the side of the pharmaceutical companies and has yet to embrace marijuana as a treatment due to its schedule 1 status. “We don’t let companies market products that deliberately prey on sick people with baseless claims that their substance can shrink or cure cancer and we’re not going to look the other way on enforcing these principles when it comes to marijuana-containing products.”
The companies targeted by the FDA include Greenroads Health, That’s Natural Marketing, Stanley Brothers Enterprises, and Natural Alchemist. The four companies marketed various CBD products in the US online. Claims made by the companies included “combats tumor and cancer cells” and similar statements that the FDA disapproved of. Whether or not the statements had any validity is not the issue. The FDA was not kept in the loop with the four companies products which made it to shelves without FDA approval.
The FDA is another branch of the US government that has been compromised by corporate entities, primarily the pharmaceutical industry, who is legal marijuana’s arch nemesis. The FDA has approved the use of amphetamines and opioids for children as young as the age of 7, yet harmless products containing CBD become the target of investigations. It was only a matter of time before the FDA began to crack down on products like this. As it stands, marijuana is still seemingly enemy #1 the US, despite the overwhelming support for legalization.